Over recent years there have been increasing numbers of knee replacements performed in the UK. In the majority of cases these are successful procedures which allow patients to lead more active lives and greatly improve their joint symptoms.
Over time such replacements may become problematic for a variety of reasons causing patients to experience further pain, swelling, stiffness or instability. This can, in turn, limit patients by reducing their ability to perform desired activities.
For some situations, there is a lack of high quality evidence (such as well-designed trials) regarding the assessment, management and rehabilitation of this group of patients. This insufficient up-to date information can leave patients, carers and clinicians faced with uncertainties regarding the best way to move forward.
Who is involved in the Partnership?
Organisations and individuals have been invited to join the PSP representing the following groups:
Who does this Partnership want to hear from?
We are interested in patients who have / had problems following knee replacement, their carers and the health professionals who deal with this group.
What is the aim of this process?
The aim of the Revision Knee Replacement PSP is to identify these uncertainties about the assessment, management or rehabilitation of patients with problematic knee replacements, from patient and clinical perspectives.
We will then prioritise the research questions those that patients and clinicians agree are the most important.
What are the objectives of this process?
· work with patients and clinicians to identify uncertainties about the assessment, management and rehabilitation of patients with problematic knee replacements
· to agree by consensus a prioritised list of those uncertainties, for research
· to publicise the results of the PSP and process
· to take the results to research commissioning bodies to be considered for funding.
Priority Setting Partnerships (PSPs) enable clinicians, patients and carers to work together to identify and prioritise uncertainties about the effects of treatments that could be answered by research. While the James Lind Alliance (JLA) facilitates these partnerships, the funding and organising is done by the PSP itself.